NIQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NIQ is not a good buy right now for a beginner long-term investor, especially someone who wants to act immediately with $50,000-$100,000. The stock has weak technical momentum, mixed analyst sentiment, and no strong proprietary buy signal today. While the CEO's recent insider purchase and Q1 revenue growth are positives, the current setup looks more like a watchlist name than an immediate buy.
The short-term trend is bearish. MACD histogram is negative at -0.0756, the moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5, and RSI_6 at 31.894 shows weak but not oversold momentum. Pre-market price is 8.3, slightly down 0.48%, and it is trading below the pivot level of 8.889, with immediate support at 8.087. This suggests downside pressure remains unless price reclaims the pivot area.
CEO James Peck bought 118,625 shares for about $1 million, which is a meaningful insider vote of confidence. Q1 revenue grew 11% year over year to $1.1 billion, and analysts noted strong core growth, AI-related demand, and solid execution. BMO also cited 30% long-term margin targets as a constructive longer-term signal.
The company reported an operating loss of $10.2 million in Q1 due to restructuring costs. Analysts repeatedly cut price targets across the board after Q1, citing decelerating organic growth, lighter profitability guidance, growth concerns, and lower sector multiples. The stock has also been under pressure from an 18% selloff mentioned by UBS, and the technical trend remains weak.
Latest quarter: Q1 2026. NIQ posted 11% year-over-year revenue growth to $1.1 billion, which is healthy top-line expansion. However, it also posted an operating loss of $10.2 million because of restructuring costs, so profitability was weak in the quarter despite good revenue momentum.
Analyst sentiment is mixed to mildly positive, but price targets have been cut broadly. BMO lowered PT to $11 from $16 and kept Outperform; Needham cut to $12 from $21 and kept Buy; BofA cut to $16 from $20 and kept Buy; RBC cut to $13 from $20 and kept Outperform; Stifel cut to $16 from $20 and kept Buy; UBS cut to $21 from $24 and kept Buy; Deutsche Bank cut to $14 from $18 and kept Hold; Citi is Neutral at $16. Overall, the Street still has several Buy/Outperform ratings, but the direction of travel is clearly downward on targets, reflecting near-term caution. Politicians or influential figures: no recent congress trading data; recent insider activity is positive due to the CEO purchase.
